Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis greenmarketreport Views: 394

-

- “Medical Marijuana: A Clinical Handbook” First Edition

by Samoon Ahmad M.D. and Kevin P. Hill MD MHS

We are moving quickly into uncharted territory in terms of how the medical community is finally able to dive further into cannabis research without potential legal repercussions so it is a huge advantage to see experts such as authors Samoon Ahmad M.D. and Kevin P. Hill M.D MHS share their level of knowledge with the rest of us and with other medical professionals that might need guidance regarding cannabis use in their own patients.

Today we are taking a look at “Medical Marijuana: A Clinical Handbook” to see for ourselves just what kind of solid information the expert authors have brought to the table for us.

This should be a very fascinating one to peer into so let’s get started!

-Topic Focus-

This book was written by doctors with years of experience when it comes to both dealing with patients and studying cannabis effects with other practicing physicians in mind so that they have access to the latest medical information regarding cannabis and how it might apply to various treatments with patients.

Written like a guide and easy to navigate, this book expertly covers topics ranging from the pharmacological profiles of CBD and THC, the cultural and medical implementations of cannabis, and so much more.

The goals here is to further empower and arm physicians, doctors, nurses, and other medical professionals to understand how cannabis can potenianlly impact medical treatment and to further increase the quality of care and life for more patients.

About the Author

We have two authors to take a look at with this one, both with impressive medical expertise.

Dr. Samoon Ahmad has been a practicing physician for over 25 years and brings that level of expertise to this book in fine form. He currently serves as Unit Chief of Bellevue Medical Center’s Inpatient Unit and is also a Professor in the Department of Psychiatry at NYU Grossman School of Medicine.

Kevin P. Hill, M.D., M.H.S. has authored many papers on the effects of cannabidiol as an addiction psychiatrist and Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center and Associate Professor of Psychiatry at Harvard Medical School and has engaged in many speaking events on the topic of cannabis usage, law, medical information, and more.

With their powers combined these two medical experts have put together a very useful tool for medical professionals to leverage across the world.

-Reading Experience-

“Medical Marijuana: A Clinical Handbook” is written as a reference guide and certainly reads like one. The flow that one might desire from a less serious book is not present but the compelling level of information presented in the book keeps it fascinating even for those of us who are not medical professionals.

It seems like a powerful asset for any medical professional to add to their arsenal of knowledge as much of the scientific advancement regarding cannabis has been suppressed up until recently.

This book feels like a treasure trove of solid information that is both enlightening and fascinating to read.

-Summary-

“Medical Marijuana: A Clinical Handbook” is a legitimate guide to navigating the relationship of medical treatment and health with that of cannabis consumption and it’s various potential applications.

This comprehensive medical guide will surely prove to be quite an asset to the medical community and to those of us who are willing to study and grow our own level of knowledge to live healthier lives harmoniously with cannabis.

The breakdowns of topics such as the endocannabinoid system, therapeutic applications, and so much more are truly enlightening topics to explore!

If you are interested in checking out the book for yourself then here you go:

https://www.amazon.com/Medical-Marijuana-Samoon-Ahmad-M-D/dp/197514189X/ref=sr_1_1?crid=137OB3XVOJWGO&dchild=1&keywords=medical+marijuana+a+clinical+handbook&qid=1598366200&sprefix=medical+marijuana+cli%2Caps%2C500&sr=8-1

 

 

Friday Book Club: Medical Marijuana: A Clinical Handbook on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.